Hypermethylation of DRD5 Promoter Is a Biomarker Across 12 Cancer Types-Reference-Cited by-同舟云学术

Hypermethylation of DRD5 Promoter Is a Biomarker Across 12 Cancer Types

Published:2020-11-01 Issue:11 Volume:39 Page:2052-2058
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Bai Rui¹,Mei Jinzhi²,Hu Wangxiong¹

Affiliation:

1. Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

2. Department of Pediatrics, Jinhua Hospital of Zhejiang University, Jinhua, China.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/dna.2020.5829

Reference22 articles.

1. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

2. The Physiology, Signaling, and Pharmacology of Dopamine Receptors

3. Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis

4. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

5. Prediction of Metabolic Pathway Involvement in Prokaryotic UniProtKB Data by Association Rule Mining

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression Profiles of Dopamine-Related Genes and miRNAs Regulating Their Expression in Breast Cancer;International Journal of Molecular Sciences;2024-06-14

2. Dopamine receptors gene overexpression in the microenvironment of invasive gastric cancer and its potential implications;Molecular Biology Reports;2023-06-18